LIRRH Trial for the Right-sided Colon Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorChaoxi Zhou
About this trial
The aim of this clinical trial is to compare the short- and long-term outcomes of laparoscopic ileocecal reconstruction right hemicolectomy (LIRRH) with those of traditional laparoscopic right hemicolectomy (TRH) for ascending and proximal transverse colon cancer.
Eligibility criteria
Qualifiers
Age 18-75 years
ASA physical status ≤ III
Endoscopy and biopsy-proven colon adenocarcinoma
Contrast-enhanced abdominal CT showing primary tumor located in the ascending colon or proximal transverse colon (proximal one-third)
Disqualifiers
History of hypertensive crisis or hypertensive encephalopathy.
Severe cardiopulmonary insufficiency or any other contraindication to surgery.
Uncorrectable electrolyte disturbances (e.g., potassium, calcium, magnesium).
Prior intracranial or intraspinal hemorrhage.
Trial design
Treatments tested in this trial
- Laparoscopic ileocecal-reconstruction right hemicolectomy (LIRRH)
- traditional laparoscopic right hemicolectomy (TRH)
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Chaoxi Zhou
Lead sponsor
Hebei Medical University Fourth Hospital
Sponsor institution
Source ClinicalTrials.gov